|
Market Cap (4-Jul) $8,006,598,144 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 56.82 |
EPS 0.14 |
TLX released this announcement to the ASX on 22 April 2021, 8:24. The announcement is marked as price sensitive, and is 10 page(s) in length and 1.28MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.740% short sold according to ASIC data. It was ranked the 231st most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Activities Report and App 4C for quarter ended 31 March 2021 | 22 April 2021, 8:24 |
| Japanese Renal Cancer Imaging Trial Meets Study Objectives | 21 April 2021, 8:24 |
| Launch of International NOBLE Registry for SPECT Imaging | 19 April 2021, 8:23 |
| TGA commences priority evaluation process for Illuccix | 14 April 2021, 8:20 |
You must be logged in to post a reply.
Telix Pharmaceuticals 